Researchers are convinced combining navitoclax with ruxolitinib will help people with myelofibrosis. During this demo half the folks have navitoclax and ruxolitinib. The other fifty percent have ruxolitinib and a dummy drug (placebo ).This examine aims to recognize new anticancer compounds with radiosensitizing Qualities for HNSCC. We performed sup